Drug innovations and welfare measures computed from market demand: The case of anti-cholesterol drugs

American Economic Journal: Applied Economics

Volumn 4, Issue 3, 2012, Pages 167-189

  Dunn, Abe ^a  

^a Bureau of Economic Analysis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866788380     PISSN: 19457782     EISSN: 19457790     Source Type: Journal    
DOI: 10.1257/app.4.3.167     Document Type: Article

References (37)

1. Aizcorbe, Ana, and Nicole Nestoriak. 2010. "Price Indexes for Drugs: A Review of the Issues." Bureau of Economic Analysis Working Paper WP2010-02.
2. Berndt, Ernst R., Anupa Bir, Susan H. Busch, Richard G. Frank, and Sharon-Lise T. Normand. 2002. "The Medical Treatment of Depression, 1991-1996: Productive Inefficiency, Expected Outcome Variations, and Price Indexes." Journal of Health Economics 21 (3): 373-96.
3. Berry, Steven T. 1994. "Estimating Discrete-Choice Models of Product Differentiation." RAND Journal of Economics 25 (2): 242-62.
4. Berry, Steven, James Levinsohn, and Ariel Pakes. 1995. "Automobile Prices in Market Equilibrium." Econometrica 63 (4): 841-90.
5. Berry, Steven, James Levinsohn, and Ariel Pakes. 2004. "Differentiated Products Demand Systems from a Combination of Micro and Macro Data: The New Car Market." Journal of Political Economy 112 (1): 68-105.
6. Bresnahan, Timothy F., and Robert J. Gordon, eds. 1997. The Economics of New Goods. Chicago: University of Chicago Press.
7. Chintagunta, Pradeep, Jean-Pierre Dubé, and Khim Yong Goh. 2005. "Beyond the Endogeneity Bias: The Effect of Unmeasured Brand Characteristics on Household-Level Brand Choice Models." Management Science 51 (5): 832-49.
8. Cleanthous, Paris. 2004. "Patient Welfare Implications of Innovation in the US Antidepressant Market." Unpublished.
9. Congressional Budget Office. 2008. Technological Change and the Growth of Health Care Spending. Congress of the United States, Congressional Budget Office. Washington, DC, January.
10. Cutler, David M. 1995. "Technology, Health Costs, and the NIH." Paper presented at National Institutes of Health Economics Roundtable on Biomedical Research. Cambridge, MA, September.
11. Culter, David M., and Mark McClellan. 2001. "Is Technological Change in Medicine Worth It?" Health Affairs 20 (5) 11-29.
12. Cutler, David M., Mark McClellan, Joseph P. Newhouse, and Dahlia Remler. 1998. "Are Medical Prices Declining? Evidence From Heart Attack Treatments." Quarterly Journal of Economics 113 (4): 991-1024.
13. Dunn, Abe. 2012. "Drug Innovations and Welfare Measures Computed from Market Demand; The Case of Anti-Cholesterol Drugs: Dataset." American Economic Journal: Applied Economics. http://dx.doi.org/10.1257/app.4.3.167.
14. Gaynor, Martin, and William B. Vogt. 2003. "Competition among Hospitals." RAND Journal of Economics 34 (4): 764-85.
15. Goolsbee, Austan, and Amil Petrin. 2004. "The Consumer Gains from Direct Broadcast Satellites and the Competition with Cable TV." Econometrica 72 (2): 351-81.
16. Greenstein, Shane M. 1996. "From Superminis to Supercomputers: Estimating Surplus in the Computing Market." In The Economics of New Goods, edited by Timothy F. Bresnahan and Robert J. Gordon, 329-72. Chicago: University of Chicago Press.
17. Heart Protection Study Collaborative Group. 2009. "Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels." Circulation: Cardiovascular Quality and Outcomes 2 (2): 65-72.
18. Health United States. 2009. National Center for Health Statistics. Hyattsville, MD.
19. Hellerstein, Judith. 1998. "The Importance of the Physician in the Generic versus Trade-name Prescription Decision." Rand Journal of Economics 29 (1): 108-36.
20. Iizuka, Toshi. 2007. "Experts' Agency Problems: Evidence from the Prescription Drug Market in Japan." Rand Journal of Economics 38 (3): 844-62.
21. Lucarelli, Claudio, and Sean Nicholson. 2009. "A Quality-Adjusted Price Index for Colorectal Cancer Drugs." National Bureau of Economic Research Working Paper 15174.
22. Mcfadden, Daniel L. 1981. "Econometric Models of Probabilistic Choice." In Structural Analysis of Discrete Data and Econometric Applications, edited by Charles F. Manski and Daniel L. McFadden, 198-272. Cambridge, MA: MIT Press.
23. Medical Expenditure Panel Survey (MEPS). 2007. "MEPS Household Component." http://meps.ahrq.gov. (accessed April 15, 2010).
24. National Cholesterol Education Program. 2001. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Institutes of Health, National Heart, Lung, and Blood Institute. Bethesda, MD, May.
25. Nevo, Aviv. 2003. "New Products, Quality Changes, and Welfare Measures Computed from Estimated Demand Systems." Review of Economics and Statistics 85 (2): 266-75.
26. Newhouse, Joseph P. 1992. "Medical Care Costs: How Much Welfare Loss?" Journal of Economic Perspectives 6 (3): 3-21.
27. Pakes, Ariel, Steven Berry, and James A. Levinsohn. 1993. "Applications and Limitations of Some Recent Advances in Empirical Industrial Organization: Price Indexes and the Analysis of Environmental Change." American Economic Review 83 (2): 241-46.
28. Petrin, Amil. 2002. "Quantifying the Benefits of New Products: The Case of the Minivan." Journal of Political Economy 110 (4): 705-29.
29. Romeo, Charles. 2010. "Filling Out the Instrument Set in Mixed Logit Demand Systems for Aggregate Data." Department of Justice, Antitrust Division, EAG Discussion Paper 201003.
30. Scandinavian Simvastatin Survival Study Group. 1994. "Randomised Trial of Cholesterol Lowering in 4,444 Patients with Coronary Heart Disease: the Scandinavian Simvastatin Survival Study (4S)." Lancet 344 (8934): 1383-89.
31. Smith, Sheila D., Stephen K. Heffler, and Mark S. Freeland. 2000. "The Impact of Technological Change on Health Care Cost Increases." Unpublished.
32. Smith, Sheila, Joseph P. Newhouse, and Mark S. Freeland. 2009. "Income, Insurance, and Technology: Why Does Health Spending Outpace Economic Growth." Health Affairs 28 (5): 1276-84.
33. Trajtenberg, Manuel. 1989. "The Welfare Analysis of Product Innovations, with an Application to Computed Tomography Scanners." Journal of Political Economy 97 (2): 444-79.
34. Trajtenberg, Manuel. 1990. "Product Innovations, Price Indices and the (Mis)Measurement of Economic Performance." National Bureau of Economic Research Working Paper 3261.
35. Villas-Boas, J. Miguel, and Russell S. Winer. 1999. "Endogeneity in Brand Choice Models." Management Science 45 (10): 1324-38.
36. Ward, S., M. Lloyd Jones, A. Pandor, M. Holmes, R. Ara, A. Ryan, W. Yeo, and N. Payne. 2007. "A Systematic Review and Economic Evaluation of Statins for the Prevention of Coronary Events." Health Technology Assessment, 11 (14).
37. World Health Organization. 2002. World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, October.